Literature DB >> 2653279

Use of the triplex scanner in diagnosis of deep venous thrombosis.

A V Persson1, C Jones, R Zide, E R Jewell.   

Abstract

We report our experience with 264 patients who underwent triplex scans for venous occlusive disease over a 10-month period. Venography was obtained in 30 of these patients. Correlation between the two procedures was 100%. The anatomic location of thrombosis and the extent of disease were identical in both studies. The presence of intraluminal clot by angiodynography is detected by looking for changes in the venous color-flow patterns and in the B-mode image. Newer clots have low echogenicity and are seen as large black areas in the gray-scale image. Older clots are more echogenic. The presence of enlarged venous collateral veins as well as absence of color flow and inability to compress the veins confirm the diagnosis of acute deep venous thrombosis. The results of angiodynography alone can be used safely in diagnosing acute deep venous thrombosis in patients. Equally important, treatment can be withheld safety in a patient with normal results.

Entities:  

Mesh:

Year:  1989        PMID: 2653279     DOI: 10.1001/archsurg.1989.01410050083017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

Review 1.  Diagnosis of deep vein thrombosis.

Authors:  D Bergqvist; S E Bergentz
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Prospective study of deep vein thrombosis in patients with spinal cord injury not receiving anticoagulant therapy.

Authors:  S Matsumoto; K Suda; S Iimoto; K Yasui; M Komatsu; C Ushiku; M Takahata; Y Kobayashi; Y Tojo; K Fujita; A Minami
Journal:  Spinal Cord       Date:  2015-02-03       Impact factor: 2.772

3.  Free-floating deep venous thrombosis. A retrospective analysis.

Authors:  R E Berry; J E George; W A Shaver
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

Review 4.  Noninvasive imaging of the lower extremity for deep venous thrombosis.

Authors:  D G Richlie
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.